Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Incidence of Hepatocellular Carcinoma in Iran From 1996 to 2016: A Systematic Review and Meta-Analysis Publisher Pubmed



Hassanipour S1 ; Mohammadzadeh M2 ; Mansourghanaei F1 ; Fathalipour M3 ; Joukar F1 ; Salehiniya H4, 5 ; Abdzadeh E6 ; Samadani AA1 ; Nikbakht HA7 ; Arabzozani M8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran
  2. 2. Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
  3. 3. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
  4. 4. Zabol University of Medical Sciences, Zabol, Iran
  5. 5. Department of Epidemiology and Biostatistics, Tehran University of medical sciences, Tehran, Iran
  6. 6. Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran
  7. 7. Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
  8. 8. Iranian Center of Excellence in Health Management, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran

Source: Journal of Gastrointestinal Cancer Published:2019


Abstract

Purpose: Hepatocellular carcinoma or liver cancer (LC) is one of most important cancer around the world. There are several reports about LC incidence from various Iranian locations with conflicting results. The present study aimed to accomplish a systematic review to estimate the accurate incidence rate of LC among Iranian people. Methods: This systematic review was performed based on the preferred reporting items for systematic reviews and meta-analyses (PRISMA) checklist in 2018. A literature search was conducted using international databases (Medline/PubMed, Scopus, ScienceDirect, and Google Scholar) for English papers and national databases (Scientific Information Database, MagIran, IranMedex, and IranDoc) for Persian papers which estimated incidence rate of LC in any geographical area of Iran. The incidence rate of LC was calculated using random effect model. Results: Of 171 papers in the primary searches, 15 studies were included by advanced screening and refinement. The age-standardized rate (ASR) of LC was 1.66 (95% CI 1.49–1.83) for males and 1.25 (95% CI 1.12–1.38) for females. Conclusions: The incidence rate of LC in Iran was lower in comparison to other countries. Afterwards, more studies are necessary to outline the accurate incidence rate and the trend of LC among Iranian population. © 2019, Springer Science+Business Media, LLC, part of Springer Nature.
Other Related Docs
9. Epidemiology Characteristics and Trends of Lung Cancer Incidence in Iran, Asian Pacific Journal of Cancer Prevention (2016)
10. Continued Increase in Incidence of Kidney Cancer in Iran and Its 31 Provinces, International Journal of Cancer Management (2024)
17. Incidence and Trend of Liver Cancer in Iran, Journal of the College of Physicians and Surgeons Pakistan (2016)
20. Spatial Analysis of Breast Cancer Incidence in Iran, Asian Pacific Journal of Cancer Prevention (2016)
28. Spatial Analysis of Stomach Cancer Incidence in Iran, Asian Pacific Journal of Cancer Prevention (2016)
37. The Role of Melatonin in Colorectal Cancer, Journal of Gastrointestinal Cancer (2020)
38. The Epidemiological and Histological Trend of Bladder Cancer in Iran, Journal of Cancer Research and Therapeutics (2018)